Patients either got a weekly 2.4 milligram dose of semaglutide, the active ingredient in Ozempic and Wegovy, or a placebo, for 72 weeks. The trial found ... very promising step forward in ...

Participants received weekly injections of the highest tolerated doses of Zepbound, either 10 milligrams or 15 milligrams, or Wegovy, 1.7 milligrams or 2.4 milligrams. By the end of the trial ...

trial participants received weekly injections of the highest tolerated doses of Zepbound, either 10 milligrams or 15 milligrams, or Wegovy, 1.7 milligrams or 2.4 milligrams. When the trial ...